
- Investors
Annual General Shareholders Meeting
Today, we held our Annual General Meeting of Shareholders, reflecting on our continued momentum and steady progress toward our ambition of becoming a global leader in medical dermatology.
Stay updated with Almirall’s latest news. Explore our newsroom, access multimedia resources and company information, or browse our full archive of press releases.
We are committed to maintaining transparent and proactive communication with stakeholders and the healthcare community, providing timely information on our ongoing mission to transform patients' lives through innovative skin health solutions.
Stay informed with our most recent press releases. In this section, you will find comprehensive coverage of our research advancements, strategic partnerships, and corporate milestones.
1/5

Today, we held our Annual General Meeting of Shareholders, reflecting on our continued momentum and steady progress toward our ambition of becoming a global leader in medical dermatology.

Today, we shared our financial results for the first quarter of 2026, continuing our positive trajectory and delivering performance in line with expectations and our long-term growth strategy.

Today, we shared our financial results for the first quarter of 2026, continuing our positive trajectory and delivering performance in line with expectations and our long-term growth strategy.

Today, we held our Annual General Meeting of Shareholders, reflecting on our continued momentum and steady progress toward our ambition of becoming a global leader in medical dermatology.

Today, we launch Almirall’s 2025 Year in Review, a comprehensive publication that looks back on a transformative year and captures the key achievements that shaped our progress throughout 2025.

This weekend, the 17th edition of Almirall’s Skin Academy, reaffirmed its position as a leading platform for scientific exchange, collaboration, and education in medical dermatology.

Today, we launch our new employer brand—an expression of who we are, how we work, and what drives us forward.
To support your reporting and research, we provide a selection of essential resources, including our corporate profile, high-resolution media assets, and detailed reports on our pipeline focused on medical dermatology. These materials are designed to offer a clear and in-depth perspective on Almirall’s global operations and our commitment to scientific excellence.

Our yearly figures. Discover how we performed in the last year and where we are heading. Information issued by the company to the National Stock Exchange Commission (CNMV).